Submission Process

Submission and Approval

1. The Principal Investigator should submit a completed IBSCSC Registration Form for Recombinant or Synthetic Nucleic Acid (rsNA) Experiments and Registration Form for Pathogen, Select Agents and Human Cells/Tissues (PATH) (if required)  via email to IBSCSC@etsu.edu as an attachment (Word). And submit the signature page with the original signature of the PI. 
   
   
   
2. The Chair of the IBC will review the rsNA Registration Form and request changes or additional information as necessary. The Chair will refer all registrations to the rsNA subcommittee for review and comment, and refer all requests to use Pathogens, Select Agents, or Human Cells/Tissues to PATH subcommittee for review and comment.
   
   
3. Requests to use BSL-1 organisms will be considered exempt. All requests will be reviewed to determine if the organism meets the BSL-1 definition and whether appropriate safety measures are documented. If the Chair determines organism meets the Exempt requirements, an approval will be granted within two (2) weeks. All requests will be considered at the next scheduled meeting of the committee. 
   
   
4. The full committee will review all registrations and requests at the next regularly scheduled meeting. 
    
5. A letter will be sent to the PI outlining the outcome of the review soon after the meeting. 
    
6. If the Approval Letter includes stipulations, the PI must ensure that these requirements are addressed prior to initiating work. 
    
7. Approvals will be granted for a (1) year period for all registrations. 

Renewal Process

1. New Registrations must be submitted annually.
    
2. It is the responsibility of the PI to submit a renewal registration or provide notice that the PI will discontinue registered research after the anniversary date of the approval. 
    
3.  The IBC will review the Registration Renewal at the next meeting date and a letter will be sent to the PI soon after the meeting.